Administration précoce de témozolomide après chirurgie chez des patients ayant un glioblastome de mauvais pronostic : étude de faisabilité

This publication has 20 references indexed in Scilit:

• The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma
  Neurosurgery, 2015
• Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma
  Journal of Neurosurgery, 2015
• Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles
  Neurosurgical Focus, 2014
• Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma
  Neuro-Oncology, 2009
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
  The Lancet Oncology, 2009
• Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma
  Neuro-Oncology, 2008
• Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
  The Lancet Oncology, 2008
• Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis
  Journal of Clinical Oncology, 2005
• Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
  New England Journal of Medicine, 2005
• A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
  Journal of Neurosurgery, 2001